Becton Dickinson and Company (BDX) Actualités

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form ARS - Annual Report to Security Holders

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEF 14A - Other definitive proxy statements

BD and Babson Diagnostics Launch Innovative Fingertip Blood Testing to Health Care Organizations

BD and Babson Diagnostics Launch Innovative Fingertip Blood Testing to Health Care Organizations PR...

BD Resolves Previously Disclosed SEC Investigation

BD Resolves Previously Disclosed SEC Investigation PR Newswire FRANKLIN LAKES, N.J., Dec. 16, 2024 FRANKLIN...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors

SAN DIEGO, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”...